- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/04 - Mycobacterium, e.g. Mycobacterium tuberculosis
Patent holdings for IPC class A61K 39/04
Total number of patents in this class: 1037
10-year publication summary
|
61
|
68
|
66
|
63
|
61
|
63
|
57
|
45
|
57
|
29
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1653 |
35 |
| International AIDS Vaccine Initiative, Inc. | 59 |
21 |
| Access to Advanced Health Institute | 76 |
21 |
| Statens Serum Institut | 88 |
19 |
| Vakzine Projekt Management GmbH | 29 |
19 |
| The Regents of the University of California | 19989 |
17 |
| Wisconsin Alumni Research Foundation | 3889 |
17 |
| Longhorn Vaccines and Diagnostics, LLC | 88 |
15 |
| Rutgers, The State University of New Jersey | 1896 |
15 |
| Altor BioScience, LLC | 76 |
15 |
| Immodulon Therapeutics Limited | 44 |
14 |
| The Johns Hopkins University | 5679 |
13 |
| Glaxo Group Limited | 4058 |
12 |
| The General Hospital Corporation | 4749 |
12 |
| Infectious Disease Research Institute | 45 |
12 |
| Institut Pasteur | 784 |
12 |
| Albert Einstein College of Medicine, Inc. | 576 |
11 |
| Archivel Farma, S.L. | 12 |
10 |
| The UAB Research Foundation | 644 |
10 |
| Universidad de Zaragoza | 190 |
10 |
| Other owners | 727 |